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T-kininogenase (T-kgnase) activity has been investigated in tissues of the rat and submandibular glands of 
the rat, mouse and guinea pig. Both rat and mouse submandibular homogenates howed high T-kgnase 
activity. The enzyme has been purified 360-fold from rat submandibular gland homogenate supematant 
fluid. The enzyme has an apparent molecular mass of 28 kDa and a pH optimum of 8.0 toward T-kininogen. 
It cleaved T-kininogen in catalytic quantities to release T-kinin (Ile-Ser-bradykinin) and small quantities 
of bradykinin and an unknown kinin. The activity of the enzyme was increased lo-fold in the presence of 
thiol groups (dithiothreitol) and inhibited by leupeptin (90%) and to a lesser extent by aprotinin (49%), 
TLCK (46%) and soybean trypsin inhibitor (27%). Pepstatin and PMSF did not inhibit the enzyme. Studies 
on substrate specificity, pH optimum and agents which inhibit T-kgnase activity demonstrate that this en- 
zyme is different from plasma and tissue kallikreins, cathepsin D, esterase A and esterase B (other known 
kininogenases). It is the first thiol-activated kininogenase to be reported. 
T-Kinin; T-Kininogen; T-Kininogenase; Thiol activation; Submandibular gland 
1. INTRODUCTION 
Previous studies from this laboratory have 
demonstrated that free T-kinin (Ile-Ser-brady- 
kinin) is found in blood and inflammatory fluids in 
carrageenin- and urate-induced inflammation in 
the rat [1,2]. Since T-kininogen has been shown to 
be an acute-phase protein which increases in blood 
following the inflammatory response [3-51, a 
survey of tissues was made to identify the presence 
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of T-kininogenase (T-kgnase) enzymes, i.e. en-. 
zymes that release T-kinin from T-kininogen. We 
then purified T-kgnase from the rat subman- 
dibular gland which showed very high enzyme ac- 
tivity. 
2. MATERIALS AND METHODS 
2.1. Animals 
Male Sprague-Dawley rats (200-300 g), male 
Hartley guinea pigs (250-300 g) and male ICR mice 
(20-25 g) were used. 
2.2. Materials 
Aprotinin (bovine lung), SBTI, TLCK and 
PMSF were obtained from Sigma. Leupeptin and 
pepstatin were obtained from Boehringer Man- 
nheim. Sephadex G-200, DEAE-Sephadex A-50 
and CH-Sepharose 4B were obtained from Phar- 
macia. Dithiothreitol and the other SDS-PAGE 
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chemicals were obtained from Bio-Rad. T-Kinin- 
ogen was prepared as described by Okamoto and 
Greenbaum [9]. 
2.3. Tissue extract preparation 
The animals were killed in a CO2 chamber. The 
excised tissues were blotted, minced, weighed and 
homogenized in 5 vols cold saline using a Polytron 
homogenizer. The homogenates were centrifuged 
at 4°C at 20 000 x g for 15 min and the supernatant 
fluid assayed for T-kgnase activity. 
2.4. T-kgnase assay 
The incubation mixture was prepared with 50 
mM Tris-HCl buffer (pH 8.0) containing 5 pg T- 
kininogen, 20 ~1 of 30 mM o-phenanthroline and 
when appropriate 10 ~1 of 20 mM dithiothreitol. 
l-10 ~1 homogenate supernatant fluid (diluted 
lo-fold in the case of the rat mouse submandibular 
glands) was added to bring the volume to 200 ~1. 
The reaction proceeded for 30 min at 37°C. The 
solution was boiled for 10 min and a 100 ~1 sample 
was radioimmunoassayed for kinins [l]. In ex- 
periments involving inhibitors, the inhibitor was 
added at a final concentration of 10d5 M to the 
reaction mixture. 
One unit of the enzyme is defined as the amount 
of the enzyme which releases 1 ng T-kinin in 30 
min under the above conditions. Specific activity is 
expressed as U/mg protein. 
2.5. Kallikrein assay 
Kallikrein activity was measured using the 
fluorogenic peptide substrate Pro-Phe-Arg-MCA 
according to Kato et al. [6]. 
2.6. Purification of T-kgnase from rat subman- 
dibular gland 
All purification procedures were carried out at 
4°C. During the purification, the activities in the 
fractions were assayed against two different 
substrates, T-kininogen and Pro-Phe-Arg-MCA, 
in order to separate T-kgnase from kallikrein-like 
enzymes. The 20 000 x g supernatant fluid (section 
2.3) was recentrifuged at 1OOOOOxg for 60 min. 
The resultant supernatant fluid was fractioned 
with solid ammonium sulfate and the precipitate 
between 30 and 100% saturation was collected. 
The precipitate was dissolved in distilled water and 
dialyzed for 24 h against 0.01 M sodium phosphate 
buffer (pH 7.2) containing 0.1 M NaCl (0.1 M 
NaCl has been found to stabilize the purified en- 
zyme). The dialyzate was applied to a column of 
Sephadex G-200 (1.5 x 30 cm) previously equilib- 
rated with the dialysis buffer. The fractions with 
T-kgnase activities were pooled and applied to 
DEAE-Sephadex A-50 column (1.2 x 25 cm) pre- 
viously equilibrated with the same buffer. After 
washing the column with 50 ml buffer, the elution 
was performed by a linear gradient of 150 ml 
equilibrating buffer against 150 ml of the same 
buffer with 0.5 M NaCl. The flow rate was 30 ml/h 
and 3.3-ml volumes were collected. The fractions 
having T-kgnase activity were pooled, dialyzed 
against equilibrating buffer, and lyophilized. The 
leupeptin-agarose affinity column was prepared by 
coupling 25 mg leupeptin with 4 g CH-Sepharose 
4B (Pharmacia) using the carbodiimide coupling 
method according to Pharmacia. The column 
(0.9 x 20 cm) was equilibrated with 0.01 M sodium 
phosphate buffer (pH 7.2) with 0.1 M NaCl. The 
lyophilizate from the previous step was dissolved 
in water and the conductivity was adjusted to the 
equilibrating buffer. After applying the sample 
and washing the column with 40 ml buffer, the elu- 
tion was performed with a linear gradient of 30 ml 
equilibrating buffer against 30 ml of the same buf- 
fer with 2 M NaCl. The flow rate was 12 ml/h and 
2-ml volumes were collected. The fractions with T- 
kgnase activity were pooled, dialyzed and lyophil- 
ized. 
Table 1 
Tissue content of T-kgnase 
Tissue Units enzyme/p1 homogenatea 
No DTT DTT 
Submandibular gland 
(rat) 18 75 
Submandibular gland 
(mouse) 28 56 
Submandibular gland 
(guinea pig) 0.05 0.1 
Liver (rat) 0.2 0.2 
Lung (rat) 0.2 0.4 
Heart (rat) 0.2 0.2 
Kidney (rat) 0.2 0.4 
Pancreas (rat) 0.4 0.6 
Spleen (rat) 0.02 0.09 
=DTT concentration was 10m3 M 
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Protein determination was carried out by the 
method of Lowry et al. [7], using bovine serum 
albumin as a standard. SDS-PACE was performed 
with 12.5% acrylamide by the method of Laemmli 
[B]. Reversed-phase HPLC experiments were car- 
ried out as in [4]. 
3. RESULTS 
Table 1 demonstrates that all tissues assayed had 
low levels of T-kgnase activity. The submandibular 
glands of the rat and mouse had much higher 
levels. The submandibular homogenates in the 
presence of dithiothreitol increased their T-kgnase 
activity 2-5-fold. The guinea pig submandibular 
gland showed no activity. 
We have examined the effect of number of in- 
hibitors on T-kgnase activity of the rat subman- 
dibular gland homogenates (table 2). Leupeptin 
Table 2 
Effect of agents on T-kgnase from rat submandibular 
gland 
Agent Units of enzyme % inhibition 
None 82 _ 
Leupeptin 11 87 
Aprotinin 42 49 
TLCK 45 46 
SBTI 60 27 
Pepstatin 82 0 
PMSF 82 0 
Homogenate supernatant fluid was preincubated with 
lo-’ M agent for 15 min at 37°C before incubation with 
T-kininogen in the presence of low3 M DTT for 30 min 
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strongly inhibited this activity. Aprotinin, TLCK 
and SBTI had lesser inhibitory actions. Pepstatin 
and Ph;lSF had no inhibitory activity. 
Table 3 summarizes the steps for purification 
from the submandibular gland of 10 rats, 7 days 
post-injection with Freunds complete adjuvant. 
During the chromatography using DEAE-Sephad- 
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Fig. 1. Leupeptin-agarose affinity chromatography. 5 mg 
protein were loaded onto a column (0.9~ 20 cm) 
previously equilibrated with 0.01 M sodium phosphate 
(pH 7.2) with 0.1 M NaCI. The elution was performed 
with a linear salt gradient (0.1-2.0 M NaCl); flow rate, 
12 ml/h; 2 ml per fraction collected. (m) Kallikrein 
activity, (o----o) T-kgnase. 
Table 3 
Purification of T-kgnase from rat submandibular gland 
Treatment ‘Units/ml Total/units Protein Specific Purification Yield 
(x 10-3) (x 10e3) (mg/ml) activity (-fold) (Q) 
(x 10-3) 
100000 x supernatant g fluid 75 1200 11.9 6 1.0 100 
Ammonium sulfate 70 1131 8.8 8 1.3 94 
(30-100%) 
Sephadex G-200 44 1630 2.6 17 2.7 86 
DEAE-Sephadex A-50 32 518 0.34 95 15.0 43 
Leupeptin-agarose 26 436 0.01 2184 360 35 
‘One unit of enzyme is the amount of the enzyme which releases 1 ng T-kinin in 30 min at 37°C 
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ex A-50, T-kgnase activity was eluted as a broad 
peak at a conductivity of 8 nW’ (not shown). 
Pooled fractions (50-80) from DEAE-Sephadex 
A-50 were applied to the leupeptin-agarose affinity 
column. In this chromatography, most of the T- 
kgnase activity was eluted with high salt concentra- 
tion (fig. 1). Those fractions with high T-kgnase ac- 
tivity showed almost no Pro-Phe-Arg-MCA 
activity, and reached a 360-fold purification from 
the original supernatant. All further characteriza- 
tion was performed with pooled material eluted 
from the leupeptin-agarose affinity column. SDS- 
PAGE (fig.2) gave a single band with non-reduced 
T-kgnase with an apparent molecular mass of 28 
kDa. However, SDS-PAGE of T-kgnase reduced 
with mercaptoethanol gave two bands of 22 and 6 
kDa. These data suggest that T-kgnase is com- 
posed of a heavy chain (22 kDa) and a light chain 
(6 kDa) linked together through a disulfide bridge. 
Fig.3 shows reversed-phase HPLC of kinins 
released from T-kininogen by T-kgnase. This ex- 
periment indicates that T-kinin was the major 
kinin released, A small amount of bradykinin and 
15- 
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Fig.3. Reversed-phase HPLC of kinins released from T- 
kininogen by T-kgnase. 30 ng kinins was injected into 
the column (ODS; 4.6 x 25 cm). Kinins were eluted with 
a solvent system of 0.04 M triethylammonium formate 
buffer (pH 4.0)/acetonitrile (80:20) for the first 40 min, 
then with a linear gradient of acetonitrile (20-50%) for 
the last 40 min. Flow rate was 0.75 ml/min; quantitation 
was by radioimmunoassay. 
(>-o without DTT 
o-o with ImM DTT 
0 
12 3 4 5 6 7 8 91011 
PH 
Fig.2. SDS-PAGE of T-kgnase, (A) Non-reduced gel, Fig.4. Effects of dithiothreitol and pH on T-kgnase ac- 
(B) reduced gel. Molecular mass standards: (1) tivity. 0.2 pg purified T-kgnase was incubated with 5 pg 
phosphorylase b (92.5 kDa); (2) bovine serum albumin T-kininogen for 30 min at 37°C in the absence (M) 
(67.0 kDa); (3) ovalbumin (45.0 kDa); (4) carbonic and presence (o--o ) of 1 mM dithiothreitol at dif- 
anhydrase (31 .O kDa); (5) soybean trypsin inhibitor (21.5 ferent pH values. 50 mM sodium acetate for pH 4-6; 50 
kDa); (6) lysozyme kDa (14.0 kDa). All stained with mM Tris-HCl for pH 7-8; 50 mM sodium bicarbonate 
Coomassie brilliant blue G-250. for pH 9-11. 
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unknown kinin was also observed. 
Studies showed that T-kgnase had a pH op- 
timum of 8.0. In the presence of 1 mM dithio- 
threitol its activity increased about lo-fold (fig.4). 
4. DISCUSSION 
A number of enzymes have been reported to 
release T-kinin (Ile-Ser-bradykinin) from T- 
kininogen. Okamoto and Greenbaum [lO,l l] were 
the first to demonstrate that trypsin releases T- 
kinin from T-kininogen in rat blood. They also 
demonstrated that cathepsin D released T-kinin 
from T-kininogen at acidic pH. A cathepsin E-like 
protease and 72 kDa proteinase have been reported 
to release T-kinin from T-kininogen by a con- 
secutive cleavage of the protein [12]. An acidic 
protease of Murphy-Sturm lymphosarcoma has 
been reported to release T-kinin [13]. In addition 
to these kininogenases, the submandibular gland 
of the rat contains a variety of proteases which 
have kininogenase activity; these include kallikrein 
[14], tonin [15], esterase A 1161 and B [17]. The 
thiol-activated T-kininogenase as reported here is 
unique and termed by us ‘T-kgnase’. From the 
substrate specificity, pH optimum and response to 
inhibitors, T-kgnase differs from other known 
kininogenases. In this regard, it is of interest that 
T-kininogen is known to be a thiol protease in- 
hibitor [18]. The current findings would indicate 
that it binds to thiol proteases and in the case of T- 
kgnase acts as a substrate for this enzyme. Moreau 
et al. [19] have made the claim that T-kininogen is 
not a true kininogen since trypsin is required in 
stoichiometric amounts to release T-kinin. The 
current report clearly demonstrates that T-kgnase, 
present in submandibular glands of the rat and 
mouse, can utilize T-kininogen as a substrate. The 
enzyme acts in catalytic quantities in the presence 
of thiol groups. The conclusion is reached that 
T-kininogen is a substrate for the release of the 
vasoactive mediator T-kinin. This is of special im- 
portance since it is an acute-phase protein [4,20]. 
Thiol groups may serve as a regulator of T-kgnase 
activity and T-kinin release from T-kininogen. 
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